Mechanistically, B cell translocation gene 3 (BTG3) was identified as a direct downstream target of miR-519c-3p, which acts as a tumor promoter in regulating HCC growth and metastasis by targeting BTG3 and may become a new therapeutic target for HCC (Wang et al., 2019). The gene discussed is BTG3; the disease is hepatocellular carcinoma.